{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:54:02Z","timestamp":1762282442594,"version":"build-2065373602"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["IR.TUMS.43337"],"award-info":[{"award-number":["IR.TUMS.43337"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Given the urgent need for more specific, sensitive, and non-invasive markers for prostate cancer screening and differential diagnosis, circulating miRNAs have emerged as valuable candidates. Sixty seven prostate cancer subjects in different stages were included in this study. The participants were categorized into groups based on their pathological characteristics as local, biochemical relapse and metastatic. We retrieved eligible datasets from GEO database to identify stage-specific differentially expressed up\/down-regulated genes. Cytohubba, built-in application of Cytoscape software, and Reactome pathway database were applied to select hub genes. To select upstream miRNAs, we utilized the MiRWalk and miRNet online tools. To construct the miRNA-mRNA regulatory networks, we employed rna22. Finally, three miRNAs and five target genes were validated in peripheral blood mononuclear cells of PCa patients compared with benign prostate hyperplasia. PSA level was also measured using ELISA. Our findings revealed the potential role of PRC1 and UBA52 to be used as biomarkers for the metastatic stage, RCC1 for both biochemical relapse, and metastatic subjects. Furthermore, elevated levels of miR-124-3p and downregulation of miR-133a-3p can be introduced as biochemical relapse stage identifier. We also identified the tumor suppressor role of miR-17-5p, which was associated with higher Gleason scores. We propose PRC1, UBA52, RCC1, miR-124-3p and miR133a-3p as stage-specific PCa identifiers.<\/jats:p>","DOI":"10.1371\/journal.pone.0315366","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:42:51Z","timestamp":1762281771000},"page":"e0315366","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of stage-specific microRNAs and target genes for prostate cancer: Utilizing bioinformatics tools for diagnostic marker discovery"],"prefix":"10.1371","volume":"20","author":[{"given":"Mahsa","family":"Yaghobinejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Naji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Mohammad","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheib","family":"Aryanezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solmaz","family":"Khalighfard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Asadollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Takzare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-9974","authenticated-orcid":true,"given":"Tayebeh","family":"Rastegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"4","key":"pone.0315366.ref001","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1172\/JCI132031","article-title":"Genomics of lethal prostate cancer at diagnosis and castration resistance","volume":"130","author":"J Mateo","year":"2020","journal-title":"J Clin Invest"},{"key":"pone.0315366.ref002","first-page":"1","article-title":"Targeting PI3K\/Akt signaling in prostate cancer therapy","author":"M Hashemi","year":"2022","journal-title":"Journal of cell communication and signaling"},{"issue":"2","key":"pone.0315366.ref003","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/1055-9965.EPI-23-1034","article-title":"Trends of prostate cancer morbidity in low-Incidence countries from 1990-2019","volume":"33","author":"J Jiang","year":"2024","journal-title":"Cancer epidemiol biomarkers prev"},{"issue":"11","key":"pone.0315366.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224071","article-title":"Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer","volume":"14","author":"S Verma","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"pone.0315366.ref005","doi-asserted-by":"crossref","first-page":"152375","DOI":"10.1016\/j.prp.2019.03.004","article-title":"The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis","volume":"215","author":"S He","year":"2019","journal-title":"Pathol Res Pract"},{"issue":"10","key":"pone.0315366.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076994","article-title":"MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214","volume":"8","author":"A Srivastava","year":"2013","journal-title":"PLoS One"},{"key":"pone.0315366.ref007","doi-asserted-by":"crossref","first-page":"101445","DOI":"10.1016\/j.genrep.2021.101445","article-title":"Gene expression analysis of RCC1, VAV2, RPA3, and SRPK1 for human cervical cancer biomarkers","volume":"26","author":"P Aobchey","year":"2022","journal-title":"Gene reports"},{"issue":"1","key":"pone.0315366.ref008","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13046-018-0993-y","article-title":"Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis","volume":"37","author":"X Zhang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"pone.0315366.ref009","first-page":"984","article-title":"MicroRNA-124-3p directly targets PDCD6 to inhibit metastasis in breast cancer","volume":"15","author":"L Zhang","year":"2018","journal-title":"Oncol Lett"},{"issue":"1","key":"pone.0315366.ref010","first-page":"1","article-title":"MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling","author":"Y Fang","year":"2015","journal-title":"J Biol Res (Thessalon)"},{"key":"pone.0315366.ref011","article-title":"The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis","author":"W Zhang","year":"2022","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"},{"issue":"41","key":"pone.0315366.ref012","doi-asserted-by":"crossref","first-page":"71206","DOI":"10.18632\/oncotarget.19331","article-title":"OncomiR-17-5p: alarm signal in cancer?","volume":"8","author":"MR Bobbili","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"pone.0315366.ref013","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/ijms17121987","article-title":"Tools for sequence-based miRNA target prediction: What to choose?","volume":"17","author":"\u00c1L Riffo-Campos","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0315366.ref014","first-page":"1","article-title":"MicroRNA-133a-3p suppresses malignant behavior of non-small cell lung cancer cells by negatively regulating ERBB2","volume":"21","author":"Y Xu","year":"2021","journal-title":"Oncol Lett"},{"key":"pone.0315366.ref015","article-title":"Role of miRNAs in prostate cancer: Do we really know everything?","author":"G Cochetti","year":"2020","journal-title":"Urologic oncology: seminars and original investigations"},{"key":"pone.0315366.ref016","doi-asserted-by":"crossref","DOI":"10.1177\/11779322221115545","article-title":"Multiple myeloma: Bioinformatic analysis for identification of key genes and pathways","volume":"16","author":"C Saadoune","year":"2022","journal-title":"Bioinform Biol Insights"},{"key":"pone.0315366.ref017","article-title":"Identification of the key MicroRNAs and the miRNA-mRNA regulatory pathways in prostate cancer by bioinformatics methods","author":"D Li","year":"2018","journal-title":"BioMed Research International"},{"key":"pone.0315366.ref018","article-title":"Construction of potential gene expression and regulation networks in prostate cancer using bioinformatics tools","author":"H Liu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"pone.0315366.ref019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12881-019-0923-7","article-title":"Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis","volume":"20","author":"J Sun","year":"2019","journal-title":"BMC Med Genet"},{"issue":"7","key":"pone.0315366.ref020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","article-title":"Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the prostate cancer clinical trials working group","volume":"26","author":"HI Scher","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0315366.ref021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13250-1","article-title":"Differential expression of miR-93 and miR-21 in granulosa cells and follicular fluid of polycystic ovary syndrome associating with different phenotypes","volume":"7","author":"M Naji","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0315366.ref022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/pros.24258","article-title":"Spatial and temporal patterns of prostate cancer burden and their association with socio\u2010demographic index in Asia, 1990\u20132019","volume":"82","author":"L Luo","year":"2022","journal-title":"The Prostate"},{"key":"pone.0315366.ref023","doi-asserted-by":"crossref","first-page":"1142275","DOI":"10.3389\/fonc.2023.1142275","article-title":"A systematic method introduced a common lncRNA-miRNA-mRNA network in the different stages of prostate cancer","volume":"13","author":"G Vahabzadeh","year":"2023","journal-title":"Front Oncol"},{"key":"pone.0315366.ref024","doi-asserted-by":"crossref","first-page":"1142275","DOI":"10.3389\/fonc.2023.1142275","article-title":"A systematic method introduced a common lncRNA-miRNA-mRNA network in the different stages of prostate cancer","volume":"13","author":"G Vahabzadeh","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"pone.0315366.ref025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/ol.2021.12718","article-title":"MicroRNA-133a-3p suppresses malignant behavior of non-small cell lung cancer cells by negatively regulating ERBB2","volume":"21","author":"Y Xu","year":"2021","journal-title":"Oncol Lett"},{"issue":"3","key":"pone.0315366.ref026","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3892\/ol.2021.12910","article-title":"MicroRNA-133a-3p inhibits cell proliferation, migration and invasion in colorectal cancer by targeting AQP1","volume":"22","author":"B Kong","year":"2021","journal-title":"Oncol Lett"},{"issue":"43","key":"pone.0315366.ref027","doi-asserted-by":"crossref","first-page":"27256","DOI":"10.18632\/oncotarget.25535","article-title":"Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer","volume":"9","author":"D Weber","year":"2018","journal-title":"Oncotarget"},{"key":"pone.0315366.ref028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0813-4","article-title":"Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K\/AKT signaling","volume":"37","author":"Y Tang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"pone.0315366.ref029","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23063","article-title":"Aberrant expression of a five\u2010microRNA signature in breast carcinoma as a promising biomarker for diagnosis","volume":"34","author":"A Bitaraf","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"pone.0315366.ref030","doi-asserted-by":"crossref","first-page":"536875","DOI":"10.3389\/fonc.2020.536875","article-title":"M6A RNA methylation regulator HNRNPC contributes to tumorigenesis and predicts prognosis in glioblastoma multiforme","volume":"10","author":"L-c Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0315366.ref031","doi-asserted-by":"crossref","first-page":"6319685","DOI":"10.1155\/2022\/6319685","article-title":"hnRNPC promotes malignancy in pancreatic cancer through stabilization of IQGAP3","volume":"2022","author":"N Yang","year":"2022","journal-title":"Biomed Res Int"},{"key":"pone.0315366.ref032","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.2147\/CMAR.S330713","article-title":"HNRNPC promotes proliferation, metastasis and predicts prognosis in prostate cancer","author":"S Wang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"pone.0315366.ref033","first-page":"1","article-title":"RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer","volume":"38","author":"M Yan","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"pone.0315366.ref034","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/MCB.00443-12","article-title":"Heterogeneous nuclear ribonucleoprotein C1\/C2 controls the metastatic potential of glioblastoma by regulating PDCD4","volume":"32","author":"YM Park","year":"2012","journal-title":"Mol Cell Biol"},{"issue":"4","key":"pone.0315366.ref035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1073\/pnas.94.4.1064","article-title":"RNA-dependent phosphorylation of a nuclear RNA binding protein","volume":"94","author":"PA Fung","year":"1997","journal-title":"Proc Natl Acad Sci"},{"issue":"23","key":"pone.0315366.ref036","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100923","article-title":"Friend and foe, HNRNPC takes on immunostimulatory RNA s in breast cancer cells","volume":"37","author":"SL Sarbanes","year":"2018","journal-title":"EMBO J"},{"key":"pone.0315366.ref037","article-title":"PD59-10 exosomal HNRNPC promotes the lymphatic metastasis of prostate cancer","volume":"203","author":"C Chen","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"pone.0315366.ref038","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40364-022-00366-4","article-title":"An analysis of the role of HnRNP C dysregulation in cancers","volume":"10","author":"L Mo","year":"2022","journal-title":"Biomark Res"},{"issue":"14","key":"pone.0315366.ref039","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2174\/1871530323666230303092243","article-title":"Mitotic kinase inhibitors as therapeutic interventions for prostate cancer: evidence from In vitro studies","volume":"23","author":"A Javed","year":"2023","journal-title":"Endocr metab immune disord drug targets"},{"key":"pone.0315366.ref040","article-title":"Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer","volume":"11","author":"S-B Shin","year":"2019","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"pone.0315366.ref041","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/kjm2.12766","article-title":"EGFR\u2010mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells","volume":"40","author":"YS Pu","year":"2024","journal-title":"Kaohsiung J Med Sci"},{"issue":"24","key":"pone.0315366.ref042","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/onc.2012.309","article-title":"Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis","volume":"32","author":"A Deeraksa","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"pone.0315366.ref043","first-page":"685","article-title":"Overexpression of PRC1 indicates a poor prognosis in ovarian cancer","volume":"56","author":"H Bu","year":"2020","journal-title":"Int J Oncol"},{"issue":"1","key":"pone.0315366.ref044","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.trecan.2017.11.002","article-title":"PRC1: Linking cytokinesis, chromosomal instability, and cancer evolution","volume":"4","author":"J Li","year":"2018","journal-title":"Trends Cancer"},{"key":"pone.0315366.ref045","doi-asserted-by":"crossref","unstructured":"Chen X, Hou D, Dong S, Ai X, Qin Z, Li H, et al. A pan-cancer analysis of the oncogenic role of protein regulator of cytokinesis 1 (PRC1) in human tumors. 2022.","DOI":"10.21203\/rs.3.rs-1802682\/v1"},{"issue":"2","key":"pone.0315366.ref046","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccell.2019.07.006","article-title":"A positive step toward understanding double-negative metastatic prostate cancer","volume":"36","author":"MM Shen","year":"2019","journal-title":"Cancer Cell"},{"key":"pone.0315366.ref047","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biopha.2016.01.004","article-title":"Protein regulator of cytokinesis 1 overexpression predicts biochemical recurrence in men with prostate cancer","volume":"78","author":"H-W Luo","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"pone.0315366.ref048","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/2211536608666190919161849","article-title":"MicroRNAs determining carcinogenesis by regulating oncogenes and tumor suppressor genes during cell cycle","volume":"9","author":"Z Fasoulakis","year":"2020","journal-title":"Microrna"},{"key":"pone.0315366.ref049"},{"key":"pone.0315366.ref050"},{"key":"pone.0315366.ref051"},{"key":"pone.0315366.ref052"},{"key":"pone.0315366.ref053"},{"key":"pone.0315366.ref054"},{"issue":"12","key":"pone.0315366.ref055","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/ijc.31273","article-title":"Exome sequencing and case-control analyses identify RCC1 as a candidate breast cancer susceptibility gene","volume":"142","author":"A Riahi","year":"2018","journal-title":"Int J Cancer"},{"issue":"1","key":"pone.0315366.ref056","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/BST20210861","article-title":"The intricate roles of RCC1 in normal cells and cancer cells","volume":"50","author":"L Jing","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"pone.0315366.ref057","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fmolb.2020.00225","article-title":"The multifaceted roles of RCC1 in tumorigenesis","volume":"7","author":"X Ren","year":"2020","journal-title":"Front Mol Biosci"},{"key":"pone.0315366.ref058","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.858514","article-title":"Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways","volume":"9","author":"A Suraweera","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"9","key":"pone.0315366.ref059","doi-asserted-by":"crossref","first-page":"15963","DOI":"10.1002\/jcb.28873","article-title":"An ego network analysis approach identified important biomarkers with an association to progression and metastasis of gastric cancer","volume":"120","author":"X Tian","year":"2019","journal-title":"J Cell Biochem"},{"issue":"3","key":"pone.0315366.ref060","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: A brief overview","volume":"12","author":"D Jovic","year":"2022","journal-title":"Clin Transl Med"},{"key":"pone.0315366.ref061"},{"issue":"1","key":"pone.0315366.ref062","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40001-014-0047-7","article-title":"Network analysis of ChIP-Seq data reveals key genes in prostate cancer","volume":"19","author":"Y Zhang","year":"2014","journal-title":"Eur J Med Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:43:04Z","timestamp":1762281784000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315366"}},"subtitle":[],"editor":[{"given":"Divijendra Natha Reddy","family":"Sirigiri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":62,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0315366","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}